Biotech

Alzheimer’s Disease and the Growing Dementia Epidemic

Most of us know someone—relative, friend, or colleague—suffering from dementia, a medical term that describes symptoms of impaired cognition (memory and thinking), behavior, social abilities, and daily functioning. Dementia isn’t a specific disease and can range in severity from mild to severe. It has many different non-reversible and reversible causes.

Alzheimer’s, a progressive degenerative brain …

Middle Market Investment Banking Firm FOCUS LLC Represents the Bioline Group of Companies in its Sale to Meridian Bioscience, Inc. Deal Marks Tenth Deal for FOCUS in 2010

Bioline has been acquired by Meridian Bioscience, Inc.

Washington DC (July 23, 2010) – FOCUS LLC, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that the Bioline group of companies has been acquired by Meridian Bioscience, Inc. (NASDAQ: VIVO). FOCUS represented Bioline in this transaction.

The acquisition included the purchase of all the outstanding …